Faecal Calprotectin Testing Market Overview
According to the latest research by Future Market Insights, the Faecal Calprotectin Testing Market will witness growth during 2021-2031. With current researches paving the path for further in depth study which will give minimum discomfort to the victims of this disorder are a positive sign for the faecal extraction systems market.
With increase in prevalence of inflammatory bowel syndromes and cancer, this market will receive boost due to scientists’ will to find new ways to treat diseases in the forecast period to the global market.
What is Driving Demand for Faecal Calprotectin Testing Market?
Crohn's disease and ulcerative colitis come under the gambit of inflammatory bowel syndromes. Calprotectin is a serum which is present at site of any kind of inflammation; hence it is also called as an inflammatory marker or biomarker. Making IBS a major driver in this testing market. Changes in calprotectin levels of a faecal sample can play a major role in identifying the bowel syndromes which cause inflammation, making it a major driver of the market.
The capability of calprotectin to be able differentiate between irritable bowel syndrome and inflammatory bowel syndrome makes is a most impactful driver of this market. This uniqueness of calprotectin makes it swift in detection and treatment of bowel related diseases.
Constant alteration in the diet of individuals raise the risk of IBS and increase an individual’s susceptibility towards it. A more detailed study to understand this relation will definitely assist in making necessary changes in its testing and act as a driving factor.
Prediction of post-operative recurrence of Crohn’s disease
As published by researchers in the Digestive and Liver Disease Journal in May 2020, faecal calprotectin has a potential application in detecting the reoccurrence of Crohn’s disease.
As established earlier, Calprotectin presents itself at the site of any kind of inflammation and is therefore known as an inflammatory biomarker. This recent study shows that this serum can also act as predictive indicator in some cases. Variation in its levels in the patients with history of Crohn’s disease proved to be an indicator of recurrence of the disease. This and many future findings will help in making individuals actively do the testing and hence give a boost to the market.
U.S. and Canada Faecal Calprotectin Testing Market
According to Centre for Disease Control, colorectal cancer ranks 4th among the top 10 cancer prevalence in US. Investments and government support in conducting research in various verticals will definitely attract more attention to the faecal calprotectin market.
Developments like these showcases the encouragement provided by the authorities in developing novel systems. This will definitely aid U.S in dominating the market as there is an increase in importance of detection, prevention and treatment disease will further boost this market.
Europe Faecal Calprotectin Testing Market
European region seems to be at the front for faecal calprotectin testing. Looking at the recent developments, European authorities tend to focus on encouraging exploration of new applications in any section of healthcare sector. A very peculiar study published in the Scandinavian Journal of Gastroenterology, explored the application of calprotectin faecal testing in diagnosis of colorectal cancer, as abdominal complaints are quite common in colorectal cancer patients.
Another interesting development which makes Europe a leading market in this market, is a study conducted with an attempt establish a connection between dermatological complications and faecal calprotectin. According to this Journal of Clinical and Experimental Dermatology published article, skin lesions are very common occurrence in inflammatory bowel syndrome (IBS). Given the sensitivity of the serum calprotectin towards inflammation, proper targeted testing done in this direction will definitely give a boost to this market.
Who are the key manufacturing and supplying companies in Faecal Calprotectin Testing Market?
- Alpha Laboratories
- bioMérieux SA
- Canvax Biotech
- DRG Instruments GmbH
- Promega Corporation
- Svar Lifescience (CALPRO)
- Arbor Assays
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
By Assay Type:
- ELISA (Enzyme linked Immunosorbent Assay)
- Enzyme fluoroimmunoassay
- Quantitative immune-chromatography
- Crohn’s Disease
- Ulcerative Colitis
- Colorectal Cancer
By End User:
- Diagnostic Laboratories
- Ambulatory Care Centres
- Research Institutions
- North America
- Latin America
- South Asia
- East Asia
- Middle East & Africa